PVRL2 Antikörper
(2 Referenzen)-
- Target Alle PVRL2 Antikörper anzeigen
- PVRL2 (Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PVRL2 Antikörper ist unkonjugiert
-
Applikation
- Flow Cytometry (FACS), ELISA, Immunoprecipitation (IP)
- Spezifität
- Recognises Nectin-2, the polio retrovirus receptor-2 (PRR2)
- Aufreinigung
- Ion exchange chromatography
- Sterilität
- 0.22 μm filtered
- Immunogen
- KG-1 cell line,Myeloma X63/AG.8653 x Balb/c spleen cells
- Klon
- B-C12
- Isotyp
- IgG2b, kappa
- Top Product
- Discover our top product PVRL2 Primärantikörper
-
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 76-353) antibody
PVRL2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 58-212) antibodyPVRL2 Reaktivität: Human WB, IHC, FACS, ELISA, ICC, Neut Wirt: Maus Monoclonal 4A11B12 unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 1-479) antibodyPVRL2 Reaktivität: Human WB, ELISA, IP Wirt: Maus Monoclonal 2A6-2C1 unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) antibodyPVRL2 Reaktivität: Human FACS, IP, IHC (fro) Wirt: Maus Monoclonal R2-525 unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 83-291) antibodyPVRL2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 251-350) antibodyPVRL2 Reaktivität: Human WB, FACS, ELISA, ICC, IHC (fro), IF (p), IF (cc), IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) antibody (PE)PVRL2 Reaktivität: Human FACS Wirt: Maus Monoclonal R2-525 PE
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 1-479) antibodyPVRL2 Reaktivität: Human WB, IHC (p) Wirt: Maus Polyclonal unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 1-479) antibodyPVRL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2) (AA 76-353) antibodyPVRL2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Maus Monoclonal C6 unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
: "Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D." in: Journal of virology, Vol. 74, Issue 3, pp. 1267-74, (2000) (PubMed).
: "The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule." in: Blood, Vol. 92, Issue 12, pp. 4602-11, (1999) (PubMed).
-
: "Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D." in: Journal of virology, Vol. 74, Issue 3, pp. 1267-74, (2000) (PubMed).
-
- Target
- PVRL2 (Poliovirus Receptor-Related 2 (Herpesvirus Entry Mediator B) (PVRL2))
- Andere Bezeichnung
- CD112 (PVRL2 Produkte)
- Synonyme
- prr2 antikoerper, AI325026 antikoerper, AI987993 antikoerper, Cd112 antikoerper, MPH antikoerper, Pvr antikoerper, Pvs antikoerper, nectin-2 antikoerper, CD112 antikoerper, HVEB antikoerper, PRR2 antikoerper, PVRR2 antikoerper, nectin cell adhesion molecule 2 antikoerper, Nectin2 antikoerper, NECTIN2 antikoerper
- Hintergrund
- HVEB, PRR2
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization
-
